Validus Holdings, Ltd. (NYSE:VR) has earned an average recommendation of “Hold” from the eleven analysts that are covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, six have given a hold recommendation and two have issued a buy recommendation on the company. The average 12-month target price among brokerages that have covered the stock in the last year is $53.25.
A number of equities analysts have commented on the stock. Barclays dropped their target price on shares of Validus from $57.00 to $53.00 and set an “equal weight” rating on the stock in a research note on Monday, October 16th. Zacks Investment Research downgraded shares of Validus from a “hold” rating to a “sell” rating in a research note on Saturday, January 13th. ValuEngine downgraded shares of Validus from a “buy” rating to a “hold” rating in a research note on Wednesday, October 11th. Keefe, Bruyette & Woods restated a “hold” rating and issued a $51.00 target price on shares of Validus in a research note on Thursday, October 12th. Finally, UBS Group upped their target price on shares of Validus from $48.00 to $52.00 and gave the stock a “neutral” rating in a research note on Monday, October 30th.
In other news, President Kean Driscoll sold 6,875 shares of the stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $46.16, for a total transaction of $317,350.00. Following the transaction, the president now directly owns 110,858 shares in the company, valued at $5,117,205.28. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Over the last quarter, insiders have sold 20,625 shares of company stock worth $984,775. Insiders own 2.33% of the company’s stock.
Shares of Validus (VR) traded down $0.01 during mid-day trading on Friday, reaching $67.51. 6,003,563 shares of the company’s stock were exchanged, compared to its average volume of 2,931,098. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.95 and a quick ratio of 0.95. The company has a market cap of $5,538.99 and a P/E ratio of -103.86. Validus has a twelve month low of $41.15 and a twelve month high of $67.73.
Validus (NYSE:VR) last issued its earnings results on Thursday, February 1st. The insurance provider reported $0.05 EPS for the quarter, missing the Zacks’ consensus estimate of $1.05 by ($1.00). The company had revenue of $346.88 million during the quarter, compared to the consensus estimate of $352.00 million. Validus had a negative return on equity of 0.49% and a negative net margin of 1.38%. Validus’s revenue was up 16.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.80 earnings per share. analysts expect that Validus will post -0.23 earnings per share for the current fiscal year.
Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.
Receive News & Ratings for Validus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus and related companies with MarketBeat.com's FREE daily email newsletter.